Feasibility, Prediction and Association of Right Ventricular Free Wall Longitudinal Strain with 30-Day Mortality in Severe COVID-19 Pneumonia: A Prospective Study.
COVID-19
pneumonia
right ventricle dysfunction
speckle tracking
strain
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
23 Jun 2022
23 Jun 2022
Historique:
received:
24
05
2022
revised:
13
06
2022
accepted:
21
06
2022
entrez:
9
7
2022
pubmed:
10
7
2022
medline:
10
7
2022
Statut:
epublish
Résumé
Introduction: Right ventricular (RV) systolic dysfunction (RVsD) is a common complication of coronavirus infection 2019 disease (COVID-19). The right ventricular free wall longitudinal strain parameter (RV-FWLS) is a powerful predictor of mortality. We explored the performance of RVsD parameters for predicting 30-day mortality and the association between RV-FWLS and 30-day mortality. Methods: COVID-19 patients hospitalized at Amiens University Hospital in the critical care unit with transthoracic echocardiography were included. We measured tricuspid annular plane systolic excursion (TAPSE), the RV S’ wave, RV fractional area change (RV-FAC), and RV-FWLS. The diagnostic performance of RVsD parameters as predictors for 30-day mortality was evaluated by the area under the receiver operating characteristic (ROC) curve (AUC). RVsD was defined by an RV-FWLS < 21% to explore the association between RVsD and 30-day mortality. Results: Of the 116 patients included, 20% (n = 23/116) died and 47 had a RVsD. ROC curve analysis showed that RV-FWLS failed to predict 30-day mortality, as did conventional RV parameters (all p > 0.05). TAPSE (21 (19−26) mm vs. 24 (21−27) mm; p = 0.024) and RV-FAC (40 (35−47)% vs. 47 (41−55)%; p = 0.006) were lowered in the RVsD group. In Cox analysis, RVsD was not associated with 30-day mortality (hazard ratio = 1.12, CI 95% (0.49−2.55), p = 0.78). Conclusion: In severe COVID-19 pneumonia, RV-FWLS was not associated with 30-day mortality.
Identifiants
pubmed: 35806914
pii: jcm11133629
doi: 10.3390/jcm11133629
pmc: PMC9267479
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Thorax. 2021 Apr;76(4):412-420
pubmed: 33408195
Transplant Proc. 2012 Sep;44(7):2013-5
pubmed: 22974895
J Korean Med Sci. 2020 Oct 19;35(40):e366
pubmed: 33075857
Echocardiography. 2012 May;29(5):513-21
pubmed: 22324535
Eur Heart J Cardiovasc Imaging. 2020 Jun 1;21(6):592-598
pubmed: 32242891
Int J Cardiol. 2021 Mar 15;327:251-258
pubmed: 33242508
Anaesth Crit Care Pain Med. 2018 Dec;37(6):607-614
pubmed: 30580775
Eur Heart J Cardiovasc Imaging. 2018 Jun 1;19(6):591-600
pubmed: 29596561
J Am Soc Echocardiogr. 2020 Jun;33(6):692-734
pubmed: 32503709
JACC Cardiovasc Imaging. 2019 Sep;12(9):1849-1863
pubmed: 31488253
JACC Cardiovasc Imaging. 2020 Nov;13(11):2287-2299
pubmed: 32654963
Eur Heart J Cardiovasc Imaging. 2022 Mar 22;23(4):569-577
pubmed: 34008835
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
JAMA. 1993 Dec 22-29;270(24):2957-63
pubmed: 8254858
J Intensive Care. 2021 Jan 12;9(1):9
pubmed: 33436101
Eur J Echocardiogr. 2009 Dec;10(8):893-905
pubmed: 19889658
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
J Clin Med. 2021 Jun 08;10(12):
pubmed: 34200990
Eur J Radiol. 2022 Mar;148:110156
pubmed: 35078136
Circ Cardiovasc Imaging. 2016 Feb;9(2):e003866
pubmed: 26860970
Sci Rep. 2021 Sep 7;11(1):17774
pubmed: 34493763
Eur Heart J Cardiovasc Imaging. 2022 Jun 21;23(7):898-912
pubmed: 35147667
J Intensive Care Med. 2021 Aug;36(8):900-909
pubmed: 33783269
J Clin Med. 2022 May 06;11(9):
pubmed: 35566751
J Am Soc Echocardiogr. 2010 Jul;23(7):685-713; quiz 786-8
pubmed: 20620859
Am Heart J Plus. 2021 Jun;6:100018
pubmed: 34095889
Intensive Care Med. 2021 Jan;47(1):1-13
pubmed: 33275163
Front Cardiovasc Med. 2021 Jan 18;7:632434
pubmed: 33537350
J Cardiothorac Vasc Anesth. 2021 Dec;35(12):3594-3603
pubmed: 33558133
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14
pubmed: 25559473